Annelies Mavinkurve-Groothuis

Dr Annelies Mavinkurve-Groothuis, MD PhD, is a consultant pediatric oncologist at the Solid Oncology Department and an associate group leader at the Princess Máxima Center for Pediatric Oncology in Utrecht, NL. 

She did her PhD thesis on early detection of anthracycline-induced cardiotoxicity in children and survivors with cancer. Part of her research still focuses on the cardiotoxic effects of cancer treatments, both during and after treatment. She is involved in several guidelines of the International Late Effects of Childhood Cancer Guideline Harmonisation Group (IGHG), including the recent dexrazoxane guideline. She is a member of the pediatric group of the International Cardio-Oncology Society (IC-OS).